Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Virulizin enters phase I/II for drug-resistant HIV-related Kaposi's sarcoma

July 26, 1996

Columbia Laboratories' SPC3 undergoes phase I/II trials

July 26, 1996

Allophenylnorstatine HIV protease inhibitors described

July 26, 1996

Sequus licenses liposome-CD4 technology

July 26, 1996

Gilead Science's sulfone HIV protease inhibitors

July 26, 1996

Positive phase I/II results for PDT's SnET2 in AIDS-associated Kaposi's sarcoma patients

July 19, 1996

Interim results from ALRT-1057 phase I/II trials

July 19, 1996

CryptoGam enters phase II for cryptosporidiosis in AIDS patients

July 19, 1996

Hybridon's GEM-91 inhibits various steps in HIV-1 replication

July 19, 1996

Cel-Sci's HGP-30 vaccine associated with IgG3 isotype antibody response

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...